Kun Ji
Shenyang Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kun Ji.
Cells Tissues Organs | 2012
Wei Lu; Jinhua Yu; Yongjie Zhang; Kun Ji; Yalei Zhou; Yuan Li; Zhihong Deng; Yan Jin
Many studies demonstrate that the type of adjacent mesenchymal cells can affect epidermal morphogenesis of bilayered tissue-engineered skin. However, whether a mixture of different mesenchymal cell types can improve epidermal morphogenesis of bioengineered skin remains unknown. In this study, keratinocytes, dermal fibroblasts and adipose tissue-derived stem cells (ADSCs) were isolated and purified from human skin and subcutaneous fat. Conditioned medium generated from a mixture of dermal fibroblasts and ADSCs at the ratio of 1:1 was superior to that from fibroblasts or ADSCs alone in promoting keratinocyte proliferation, as indicated by MTT assay. Furthermore, ELISA results showed that the cytokine levels of human hepatocyte growth factor and keratinocyte growth factor (also known as FGF7) in the mixed fibroblasts/ADSC group were higher than those in the ADSC or dermal fibroblasts group. To examine the potential roles of mixed fibroblasts and ADSCs on epidermal morphogenesis, a three-dimensional tissue engineered skin system was applied. Histological analyses demonstrated that keratinocytes proliferated extensively over the mixture of fibroblasts and ADSCs, and formed a thick epidermal layer with well-differentiated structures. Keratin 10 (epidermal differentiation marker) was expressed in the suprabasal layer of bilayered tissue-engineered skin in the mixed fibroblasts and ADSCs group. Desmosomes and hemidesmosomes were detected in the newly formed epidermis by transmission electron microscopy analysis. Together, these findings revealed for the first time that a mixture of fibroblasts and ADSCs in bilayered tissue-engineered skin can improve epidermal morphogenesis.
Journal of Pharmacology and Experimental Therapeutics | 2011
Kun Ji; Bo Wang; Yueting Shao; Ling Zhang; Yanan Liu; Chen Shao; Xiaojie Li; Xin Li; Jiadi Hu; Xuejian Zhao; De-qi Xu; Yang Li; Lu Cai
Our objective was to evaluate cell growth and death effects by inhibiting Murine Double Minute 2 (MDM2) expression in human prostate cancer cells overexpressing the wild-type (WT) p53 gene. Prostate PC-3 tumor cells were transfected with a plasmid containing either mdm2 small interfering (Si-mdm2) or the WT p53 gene (Pp53) alone, or both (Pmp53), using Lipofectamine in vitro and attenuated Salmonella enterica serovar Typhi vaccine strain Ty21a (Salmonella Typhi Ty21a) in vivo. Cell growth, apoptosis, and the expression of related genes and proteins were examined in vitro and in vivo by flow cytometry and Western blot assays. We demonstrated that human prostate tumors had increased expression of MDM2 and mutant p53 proteins. Transfection of the PC-3 cells with the Pmp53 plasmid in vitro offered significant inhibition of cell growth and an increase in apoptotic cell death compared with that of the Si-mdm2 or Pp53 group. These effects were associated with up-regulation of p21 and down-regulation of hypoxia-inducible factor 1α expression in Pmp53-transfected cells. To validate the in vitro findings, the nude mice implanted with PC-3 cells were treated with attenuated Salmonella Typhi Ty21a carrying the plasmids, which showed that the Pmp53 plasmid significantly inhibited the tumor growth rate in vivo compared with that of the Si-mdm2 or Pp53 plasmid alone. Tumor tissues from mice treated with the Pmp53 plasmid showed increased expression of p21 and decreased expression of hypoxia-inducible factor 1α proteins, with an increased apoptotic effect. These results suggest that knockdown of mdm2 expression by its specific small interfering RNA with overexpression of the WT p53 gene offers synergistic inhibition of prostate cancer cell growth in vitro and in vivo.
Oncotarget | 2017
Yong Gan; Jiang Wu; Shengchao Zhang; Liqing Li; Shiyi Cao; Naomie Mkandawire; Kun Ji; Chulani Herath; Chao Gao; Hong Xu; Yanfeng Zhou; Xingyue Song; Shanquan Chen; Yawen Chen; Tingting Yang; Jing Li; Yan Qiao; Sai Hu; Xiaoxv Yin; Zuxun Lu
A meta-analysis was performed to assess the association of coffee consumption with colorectal cancer and to investigate the shape of the association. Relevant prospective cohort studies were identified by a comprehensive search of the PubMed, Embase and Web of Science databases from their inception through August 2015. Either a random-effects model or fixed-effects model was used to compute the pooled risk estimates when appropriate. Linear and nonlinear dose-response meta-analyses were also performed. Nineteen prospective cohort studies involving 2,046,575 participants and 22,629 patients with colorectal cancer were included. The risk of colon cancer was decreased by 7% for every 4 cups per day of coffee (RR=0.93, 95%CI, 0.88-0.99; P=0.199). There was a threshold approximately five cups of coffee per day, and the inverse association for colorectal cancer appeared to be stronger at a higher range of intake. However, a nonlinear association of rectal cancer with coffee consumption was not observed (P for nonlinearity = 0.214). In conclusion, coffee consumption is significantly associated with a decreased risk of colorectal cancer at ≥ 5 cups per day of coffee consumption. The findings support the recommendations of including coffee as a healthy beverage for the prevention of colorectal cancer.
conference on automation science and engineering | 2013
Yinliang Xu; Kun Ji; Yan Lu; Yuebin Yu; Wenxin Liu
The building thermal capacity can be used for shifting on-peak load and reducing peak cooling/heating in commercial and residential buildings. The optimization of the pre-cooling/pre-heating is a complicated problem of several major factors, including utility rates, load profiles, building storage characteristics and weather conditions. This paper introduces an intelligent search algorithm, Particle Swarm Optimization (PSO), to find the near optimal solution. A simulation model of a single floor with multi-zone based on a real lab building in Carnegie Mellon University is built with Energyplus to simulate the proposed algorithm. By using MLE+, the EnergyPlus model of the building becomes an S-function block in the Matlab/Simulink, and all available Matlab toolboxes can be used for control and optimization purposes. Simulation results demonstrate the feasibility and the effectiveness of the proposed method.
Scientific Reports | 2017
Junlian Gu; Yang Li; Jun Zeng; Bo Wang; Kun Ji; Yufeng Tang; Qing Sun
Resistance to cisplatin (DDP) and dose-related toxicity remain two important obstacles in the treatment of prostate cancer (PCa) patients with DDP-based chemotherapy. We have investigated whether the knockdown of hypoxia-inducible factor-1 alpha (HIF-1α) by siRNA could enhance the antitumor activity of DDP, and aimed to determine the underlying mechanisms. Intravenous injection of attenuated Salmonella carrying a HIF-1α siRNA-expressing plasmid was used to knockdown HIF-1α in a PC-3 xenograft model. The in vitro and in vivo effects of HIF-1α siRNA treatment and/or DPP on PCa cell proliferation, apoptosis, glycolysis, and production of reactive oxygen species (ROS) were assessed by examining molecular markers specific to each process. The results demonstrated that the treatment of tumor-bearing mice with attenuated Salmonella carrying the HIF-1α siRNA plasmid greatly enhanced the antitumor effects of low-dose DDP. Further mechanistic studies demonstrated that knockdown of HIF-1α improved the response of PCa cells to DDP by redirecting aerobic glycolysis toward mitochondrial oxidative phosphorylation, leading to cell death through overproduction of ROS. Our findings indicate that DDP-based chemotherapy combined with targeting the HIF-1α-regulated cancer metabolism pathway might be an ideal strategy to treat PCa.
World Journal of Gastroenterology | 2017
Baomin Shi; Wen Lu; Kun Ji; Yufeng Wang; Shuai Xiao; Xiu-Yan Wang
AIM To analyze the incidence of hepatocellular carcinoma (HCC) in a population that underwent health checkups and had high serum miR-106b levels. METHODS A total of 335 subjects who underwent checkups in the Digestive and Liver Disease Department of our hospital were randomly selected. RT-PCR was used to detect the level of miR-106b in serum samples. Laboratory and imaging examinations were carried out to confirm the HCC diagnosis in patients who had a > 2-fold change in miR-106b levels. Ultrasound-guided biopsy was also used for HCC diagnosis when necessary. On this basis, the clinical data of these subjects, including history of hepatitis virus infection, obesity, long-term history of alcohol use and stage of HCC, were collected. Then, the impact of these factors on the level of miR-106b in serum was analyzed. Furthermore, receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic efficacy of miR-106b for HCC. RESULTS A total of 35 subjects had abnormal serum miR-106b levels, of which 20 subjects were diagnosed with HCC. t-test revealed that the difference in serum miR-106b level in terms of sex, age, history of hepatitis virus infection, obesity and long-term history of alcohol use was not statistically significant. However, serum miR-106b levels in patients with advanced HCC (stage III/IV) was higher than in patients with early HCC (stage I/II), and the difference was statistically significant (P = 0.000). Moreover, the ROC curve revealed that the area under the curve value for miR-106b was 0.885, which shows that serum miR-106b level has a certain clinical value for HCC diagnosis. CONCLUSION The random sampling survey shows that serum miR-106b level is a valuable diagnostic marker for HCC. However, the diagnostic threshold value needs to be further researched.
Toxicology Research | 2015
Bo Wang; Kun Ji; Yue Wang; Yang Li; Yufeng Tang; Junlian Gu; Lu Cai
Cadmium (Cd) is classified as a human carcinogen probably associated with epigenetic change. However, its underlying mechanism and role in epigenetics is still poorly understood. DNA methylation is one of the epigenetic mechanisms by which cells control expression. Our previous in vivo experiment has shown that caspase-8 gene promoter of the rat liver tissue was hypermethylated in Cd at 20 nmol kg−1 for 4 weeks. In the present study, we will disclose whether DNA methylation is also involved in this Cd-stimulated FL83B cell proliferation. When the FL83B cells were exposed to Cd at a low dose (0.085 μM) for only 14 days, cell proliferation and DNMT methyltransferase expression and activity increased, while the mRNA and protein of tumor gene caspase-8 decreased remarkably, along with a significant decrease in cell apoptosis and increase in cell invasion and metastasis. Furthermore, caspase-8 gene promoter in Cd-exposed Fl83B cells was hypermethylated, consistent with our in vivo experiment. A DNA methylation inhibitor, 5-aza-2′-deoxycytidine (5-aza-dC), prevented Cd-stimulated cell proliferation, invasion and metastasis associated with recovered caspase-8 expression. These results suggest that low dose Cd may induce caspase-8 gene promoter hypermethylation, resulting in down-regulation of its expression, and consequently promoting cell proliferation, invasion and metastasis and decreasing apoptosis, both of which would contribute to Cd-induced carcinogenesis.
Archive | 2011
Kun Ji; Yan Lu; Linxia Liao; Zhen Song; Dong Wei
Cell and Tissue Research | 2014
Wei Lu; Kun Ji; Jennifer Kirkham; Yu Yan; Aldo R. Boccaccini; Margaret Kellett; Yan Jin; Xuebin Yang
Archive | 2012
Yan Lu; Zhen Song; Vivian Loftness; Kun Ji; Sam Zheng; Bertrand Lasternas; Flore Marion; Yu Yuebin